Atlas Trials

Primary Myelofibrosis

139 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Primary Myelofibrosis

RecordFirmDate
Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases (NCT00351975)National Cancer Institute (NCI)2006-06-01
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders (NCT00357305)National Cancer Institute (NCI)2006-05-01
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders (NCT00397813)Fred Hutchinson Cancer Center2006-01-01
Lenalidomide and Prednisone in Treating Patients With Myelofibrosis (NCT00227591)National Cancer Institute (NCI)2005-12-01
Decitabine in Treating Patients With Myelofibrosis (NCT00095784)National Cancer Institute (NCI)2004-09-29
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer (NCT00089011)Fred Hutchinson Cancer Center2004-04-01
Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia (NCT00047190)National Cancer Institute (NCI)2002-08-01
Imatinib Mesylate in Treating Patients With Myelofibrosis (NCT00039416)National Cancer Institute (NCI)2002-04-01
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction (NCT00025415)National Cancer Institute (NCI)2001-08-01
Thalidomide in Treating Patients With Myelofibrosis (NCT00015821)National Cancer Institute (NCI)2000-05-01
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593)Fred Hutchinson Cancer Center1999-11-01
Managed Access Program for Momelotinib in Myelofibrosis (NCT05582083)GlaxoSmithKline
← Previous

Track Primary Myelofibrosis automatically

Every clearance here is in the API, with alerts when new ones post.